{"alopecia": 2.33, "alpha 1 foetoprotein increased": 150.74, "anaemia": 2.23, "ascites": 6.88, "blister": 4.3, "diarrhoea": 3.25, "disease progression": 4.13, "drug ineffective for unapproved indication": 8.0, "drug intolerance": 2.37, "drug-induced liver injury": 2.74, "erythema multiforme": 6.54, "haematotoxicity": 15.46, "hepatic encephalopathy": 14.76, "hepatic failure": 8.07, "hepatocellular carcinoma": 72.34, "hepatotoxicity": 6.28, "hyperkeratosis": 26.22, "hypertension": 3.53, "hypocalcaemia": 12.63, "metastases to bone": 7.58, "metastases to lung": 32.16, "metastatic renal cell carcinoma": 27.27, "mucosal inflammation": 11.39, "off label use": 6.09, "osteonecrosis of jaw": 14.21, "palmar-plantar erythrodysaesthesia syndrome": 103.78, "product use in unapproved indication": 9.24, "product use issue": 2.69, "rash maculo-papular": 2.75, "renal cell carcinoma": 12.98, "skin exfoliation": 3.25, "skin reaction": 4.31, "skin toxicity": 60.05, "skin ulcer": 6.08, "squamous cell carcinoma of skin": 29.66, "stevens-johnson syndrome": 3.73, "stomatitis": 2.07, "thrombocytopenia": 3.94, "tumour lysis syndrome": 15.07, "weight decreased": 2.45}